CREATIVE MEDICAL TECHNOLOGY

Creative Medical (CELZ) Slides 1.63% as Biotech Sector Faces Volatility & 200‑Day MA Gap

Creative Medical (CELZ) slides below its 200‑day SMA amid biotech volatility—investors weigh stem‑cell potential vs. liquidity risks.

CREATIVE MEDICAL TECHNOLOGY
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

22/10/2026, 09:17

3 minutes to read

Creative Medical’s Ultrasome™ Pilot Shows 93% Response, Boosts CELZ Stock 4.3%

Creative Medical (CELZ) sees a 4.3 % share jump after a 93 % clinical response in its Ultrasome™ knee osteoarthritis pilot, spotlighting safety and strong pain reduction.

CREATIVE MEDICAL TECHNOLOGY
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 18:36

3 minutes to read